Please use this identifier to cite or link to this item: http://hdl.handle.net/123456789/1626
Title: 2-Deoxy-D-Glucose: A Novel Pharmacological Agent for Killing Hypoxic Tumor Cells, Oxygen Dependence-Lowering in Covid-19, and Other Pharmacological Activities
Authors: Singh, R
Gupta, V
Kumar, A
Singh, K
Issue Date: Mar-2023
Abstract: Te nonmetabolizable glucose analog 2-deoxy-D-glucose (2-DG) has shown promising pharmacological activities, including inhibition of cancerous cell growth and N-glycosylation. It has been used as a glycolysis inhibitor and as a potential energy restriction mimetic agent, inhibiting pathogen-associated molecular patterns. Radioisotope derivatives of 2-DG have applications as tracers. Recently, 2-DG has been used as an anti-COVID-19 drug to lower the need for supplemental oxygen. In the present review, various pharmaceutical properties of 2-DG are discussed.
URI: http://hdl.handle.net/123456789/1626
Appears in Collections:School of Interdisciplinary & Applied Sciences

Files in This Item:
File Description SizeFormat 
2-Deoxy-D-Glucose_A_Novel_Pharmacological_Agent_fo.pdf455.34 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.